The peptides ability to enhance fat metabolism without affecting glucose regulation makes it compatible with intense training protocols
This article is for educational purposes only and does not constitute medical advice
Perhaps most significantly, not a single serious adverse event was attributed to AOD-9604 administration across the entire trial program
Unlike GLP-1 agonists such as semaglutide or tirzepatide, which work primarily through appetite suppression, AOD-9604 directly enhances fat metabolism at the cellular level through beta-3 adrenergic receptor modulation
AOD9604 Benefits: Whats Proven and Whats Hype AOD9604 is often promoted as a fat-burning peptide, but to understand its real potential, we need to break down what the science says, whats exaggerated, and how this fits into a practical fat-loss strategy
The compound was never approved as a pharmaceutical treatment for obesity because the Phase 2 clinical trial results, while showing safety and modest efficacy, did not meet the threshold for drug registration